Commonwealth Equity Services’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-5,121
| Closed | -$241K | – | 3919 |
|
2023
Q2 | $241K | Buy |
+5,121
| New | +$241K | ﹤0.01% | 3228 |
|
2021
Q3 | – | Sell |
-4,239
| Closed | -$240K | – | 3648 |
|
2021
Q2 | $240K | Sell |
4,239
-171
| -4% | -$9.68K | ﹤0.01% | 3114 |
|
2021
Q1 | $330K | Buy |
4,410
+196
| +5% | +$14.7K | ﹤0.01% | 2684 |
|
2020
Q4 | $364K | Buy |
+4,214
| New | +$364K | ﹤0.01% | 2404 |
|
2019
Q4 | – | Sell |
-1,763
| Closed | -$247K | – | 2938 |
|
2019
Q3 | $247K | Sell |
1,763
-9
| -0.5% | -$1.26K | ﹤0.01% | 2403 |
|
2019
Q2 | $324K | Buy |
1,772
+77
| +5% | +$14.1K | ﹤0.01% | 2140 |
|
2019
Q1 | $269K | Buy |
+1,695
| New | +$269K | ﹤0.01% | 2244 |
|